Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
European Journal of Pharmacology
|
June 5, 1992
Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist
L A Tive, C G Pick, D Paul, et al.
Brain Research. Developmental Brain Research
|
October 23, 1992
Alterations in septohippocampal cholinergic innervations and related behaviors after early exposure to heroin and phencyclidine
J Yanai, Y Avraham, S Levy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1990
Naloxone benzoylhydrazone (NalBzoH) analgesia
D Paul, J A Levison, D H Howard, et al.
Neuroscience
|
August 15, 2012
The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury
J N Saykally, L Rachmany, H Hatic, et al.
Addiction Biology
|
May 17, 2003
Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice
S Schreiber, M M Backler, I Herman, et al.
The European Journal of Neuroscience
|
September 3, 2004
Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity
N Benaroya-Milshtein, N Hollander, A Apter, et al.
Neuropharmacology
|
February 1, 1993
Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways
J Yanai, Y Rogel-Fuchs, C G Pick, et al.
Neurotoxicology
|
January 1, 1989
Neural and behavioral alterations after early exposure to phenobarbital
J Yanai, F Fares, M Gavish, et al.
Journal of Autoimmunity
|
July 4, 2016
Annexin A2, autoimmunity, anxiety and depression
R Weiss, A Bitton, M Ben Shimon, et al.
Experimental Neurology
|
March 31, 2015
Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury
L-Y Yang, Y-H Chu, D Tweedie, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
European Journal of Pharmacology
|
June 5, 1992
Analgesic potency of TRIMU-5: a mixed mu 2 opioid receptor agonist/mu 1 opioid receptor antagonist
L A Tive, C G Pick, D Paul, et al.
Brain Research. Developmental Brain Research
|
October 23, 1992
Alterations in septohippocampal cholinergic innervations and related behaviors after early exposure to heroin and phencyclidine
J Yanai, Y Avraham, S Levy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1990
Naloxone benzoylhydrazone (NalBzoH) analgesia
D Paul, J A Levison, D H Howard, et al.
Neuroscience
|
August 15, 2012
The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury
J N Saykally, L Rachmany, H Hatic, et al.
Addiction Biology
|
May 17, 2003
Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice
S Schreiber, M M Backler, I Herman, et al.
The European Journal of Neuroscience
|
September 3, 2004
Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity
N Benaroya-Milshtein, N Hollander, A Apter, et al.
Neuropharmacology
|
February 1, 1993
Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways
J Yanai, Y Rogel-Fuchs, C G Pick, et al.
Neurotoxicology
|
January 1, 1989
Neural and behavioral alterations after early exposure to phenobarbital
J Yanai, F Fares, M Gavish, et al.
Journal of Autoimmunity
|
July 4, 2016
Annexin A2, autoimmunity, anxiety and depression
R Weiss, A Bitton, M Ben Shimon, et al.
Experimental Neurology
|
March 31, 2015
Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury
L-Y Yang, Y-H Chu, D Tweedie, et al.
Page
of 9